IFCT-0401 Trial: A Phase II Study of Gefitinib Administered as First-Line Treatment in Advanced Adenocarcinoma With Bronchioloalveolar Carcinoma Subtype
Journal of Thoracic Oncology- United States
doi 10.1097/jto.0b013e3181abeb5d
Full Text
Abstract
Available in
Date
September 1, 2009
Authors
Publisher
Elsevier BV